Mitosol: payments to doctors
Payments that named Mitosol as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $51K
- Providers
- 12
- Transactions
- 16
- Average per transaction
- $3,186
The per-transaction average — $3,186 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 12 providers the average total is $4,248, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Glaukos Corporation | $31,066 | 60.9% |
| Mobius Therapeutics, LLC | $19,909 | 39.1% |